Only three years after Insys Therapeutics, Inc., placed Subsys on the market in 2012, the drug has already earned record profits for the company, earning $147.2 million for Insys during the first six month of 2015 alone. Subsys is the first and only fentanyl sublingual medicine that is sprayed under the tongue and which claims to be able to relieve adults with cancer from...